Skip to main content
. 2014 Mar 26;2(3):e00275. doi: 10.1002/phy2.275

Figure 4.

Figure 4.

Associations of inhibition of adenosine triphosphate (ATP) secretion with platelet content of stable metabolites of prostacyclin (6‐k‐PGF1α) and thromboxane (TXB2) in platelets of menopausal women treated with either placebo (PL), transdermal 17β‐estradiol (tE2, 50 μg/day), or oral conjugated equine estrogen (oCEE, 0.45 mg/day) for 48 months. Each point represents an individual.